History

The Story Changed More Than the Numbers Did

For thirty years, Constellation told one story: buy small vertical-market software ("VMS") businesses at strict hurdle rates, leave them alone, compound forever. The numbers still look like that story — but the vehicle is different now. The current chapter began in February 2021, when founder Mark Leonard publicly "converted" on his lifelong hurdle-rate discipline and committed to deploy every dollar of cash, including via large LBO-style VMS deals and a new "circle of competence outside VMS." That pivot quietly produced four years of larger, more leveraged, lower-return acquisitions — Altera, WideOrbit, Optimal Blue, Empower — and culminated in something Leonard had ruled out for two decades: minority public-equity stakes in Asseco Poland and Sabre. Then on September 25, 2025, Leonard resigned as President for health reasons and the stock lost roughly half its value over six months on AI fears. Mark Miller, the long-time COO, now runs a company that is operationally intact, culturally continuous, and narratively in transition.

1. The Narrative Arc

Current CEO: Mark Miller, since September 25, 2025. Thirty-year Constellation veteran; was COO. Inherited a high-quality, owner-built business — not a turnaround.

Current strategic chapter: Began February 15, 2021, when Leonard's letter formally retired the "small/mid VMS only, no exceptions" discipline. That single letter authorized every subsequent pivot: large LBO-financed deals, public bond issuance, and minority public-equity stakes.

2. What Management Emphasized — and Then Stopped Emphasizing

Intensity scale 0 (silent) → 3 (central theme).

Three themes were quietly retired. Strict hurdle rates ("we will never lower them") was the religion of the 2017 letter — by 2021 the hurdle rate was an explicit three-tier system: 30% IRR under $1M revenue, 25% in between, 20% above $4M. The "small/mid VMS only" identity was discarded in the same letter. The annual President's Letter itself stopped — there has been no published letter since the February 2021 conversion letter, ending a 25-year communication tradition.

Three themes are entirely new. The "Permanent Engaged Minority Shareholder" (PEMS) framing for public-company minority stakes did not exist before 2025. AI as a strategic topic was absent from risk disclosures until FY2025. And conference calls — which Leonard had refused for over a decade — happened twice in eight months: an emergency AI call on September 22, 2025, and a regular Q1 2026 earnings call in May 2026 hosted by Miller and CFO Jamal Baksh.

3. Risk Evolution

Intensity scale: 0 absent → 3 central.

Three movements in the risk disclosure stand out. COVID-19 appeared as a central, lengthy risk in the FY2021 disclosure, was muted in FY2022, and was silently removed by FY2023 — a clean lifecycle. Interest rate and refinancing risk grew from a single sentence in FY2021 to a multi-paragraph disclosure by FY2024 — reflecting the $1B senior-note issuance in February 2024 and the move from secured to unsecured credit facilities. AI went from zero in every prior year to a multi-dimensional new risk in FY2025, naming competitive harm, ethical and IP issues, data privacy, cybersecurity, and "regulatory patchwork." The wording is unusually concrete for CSU — which historically wrote risk factors at a high level of abstraction — suggesting management treats AI as a real underwriting question, not boilerplate.

What is conspicuously absent: integration-of-acquisitions risk language did not escalate, even as the company shifted to LBO-style deals like Altera that have publicly dragged on margins. That is the disclosure pattern of a management team that treats integration disappointments as transient and self-correcting rather than as structural risks worth flagging.

4. How They Handled Bad News

CSU does not issue earnings press releases narrating bad news; until late 2025 there were no calls at which questions could be asked. So the test of "how they handled bad news" is mostly whether the annual letter and the risk disclosures acknowledged setbacks honestly when they occurred.

The 2021 conversion: handled exceptionally well. Leonard had argued for two decades that the company should hold the line on hurdle rates and pay out excess cash. When he changed his mind, he wrote: "I have stopped arguing. I have converted, and with the fervour of the newly converted, I am busy demonstrating my new-found faith." That is rare candor about a 180-degree reversal on the most important capital-allocation question the company faces. It set expectations that ROIC would decline and asked for shareholder patience.

Altera (Allscripts EHR, May 2022, $725M): handled quietly. This was the largest deal in CSU history and structurally different — LBO-financed, healthcare sector, in need of operational restructuring. Independent analyst work (CIBC) describes the deal as having "dragged on revenue growth and margins." CSU's own MD&A does not name Altera specifically when discussing margin pressure; management treats integration setbacks as a normal cost of business rather than a learning to be highlighted.

The September 2025 AI sell-off: handled unusually directly. CSU broke its no-conference-call posture on September 22, 2025, holding a dedicated investor call on AI's impact on VMS. Three days later, Leonard resigned for health reasons. The juxtaposition is striking but appears coincidental rather than connected — the AI call was scheduled a week in advance via a September 16 press release.

The CEO transition: handled cleanly. The September 25, 2025 announcement was specific (Leonard remains a Director; Miller's other roles unchanged; Jamal Baksh continues as CFO and primary contact). Chairman John Billowits wished Leonard "a full and swift recovery." There was no attempt to spin the change as planned succession.

5. Guidance Track Record

CSU famously gives no quantitative guidance. The "promises that mattered to valuation, credibility, or capital allocation" are therefore qualitative — directional commitments in letters, press releases, and risk-factor language. Below are the seven that meaningfully shaped how investors valued the stock.

Two important walk-backs, both pre-announced. The hurdle-rate walk-back and the conference-call walk-back were the only meaningful breaks with prior posture. Both were communicated — the hurdle change in the 2021 letter; the conference calls via press releases. Neither was discovered by investors after the fact. That matters for credibility.

The unkept piece is the non-VMS circle of competence. Five years after promising to find investable sectors outside VMS, the company's "outside" deployments are Asseco (a Polish software company) and Sabre (a U.S. travel-technology software company). Both are software businesses with VMS-like characteristics. The pivot to public minority stakes is real and disclosed; the pivot to genuinely non-VMS is not.

Why 8/10. Strong: every walk-back was pre-announced; the dividend, decentralization, and large-VMS commitments were kept; the CEO transition was clean; operational delivery has been consistent through 30 years. Deducted: the non-VMS deployment promise is five years old and effectively unmet, the absence of any annual letter since February 2021 is a quiet erosion of the disclosure quality investors relied on, and the Altera margin drag was never explicitly owned in management commentary. Not deducted but worth watching: lowering hurdle rates is a structural change that will only fully reveal itself in 5–10-year ROIC outcomes.

6. What the Story Is Now

What has been de-risked.

• CEO succession is settled. Mark Miller is a 30-year insider with the COO seat; no external search, no interregnum, no strategic reset.
• AI exposure has been disclosed and discussed publicly. Management's view (AI as feature, not margin disruptor) may be wrong, but it is not hidden. Approximately 70% of revenue sits in operating groups (Harris, Volaris, Topicus) where external analysts consider AI risk modest.
• Capital structure can now absorb large deals: $1B senior notes (5.16%/5.46%), expanded unsecured credit facility, and Topicus + Lumine as independently financed vehicles.
• Quarterly dividend has been maintained continuously — a small but unbroken anchor of capital-return discipline.

What still looks stretched.

• The "non-VMS circle of competence" promise from 2021 is five years old and has produced two public software stakes, not a genuinely new sector. Investors should discount this promise until evidence appears.
• Lowering hurdle rates for large deals is a structural change whose outcome will not be observable for at least 5 years. Altera is the first stress test and it has been painful.
• Communication has thinned out. No President's Letter for over four years. Management is now substituting earnings calls — a different medium with different incentives.
• The PEMS strategy (minority public stakes with board seats) is unproven; CSU has no track record as a public-company activist or engaged minority holder. Sabre is a debt-laden travel-tech business — quite different from CSU's traditional VMS comfort zone.

What the reader should believe vs. discount.

Believe: the decentralized model, the ROIC discipline at the BU level, the operating-group autonomy, the long-tenured leadership, and the maintenance-revenue compounding mechanic. These have survived 30 years, multiple cycles, two spin-offs, the founder's departure, and the AI sell-off. The Q1 2026 results (20% revenue growth, 6% organic, 44% FCFA2S growth) confirm the engine is still running.

Discount: any promise that requires CSU to operate outside VMS or as a minority investor or at lower hurdle rates without margin compression. None of these have a multi-year track record. The market's 2025–26 multiple compression from roughly 48× to 22× earnings is partly an AI panic, but it also reflects the genuine ambiguity about which playbook the company is now running.

The simplest framing: Constellation under Leonard pre-2021 was a disciplined small-VMS compounder. Constellation since 2021 is a compounder plus a large-VMS LBO sponsor plus an emerging public-equity engaged minority investor. The first business is among the best in the world. The second and third are works in progress. The current valuation roughly assumes the second and third never get worse than break-even — a reasonable but not free assumption.